FLUIDDA is a company focusing on respiratory solutions with the slogan "Respiratory solutions for better patient care". Founded in 2005 and headquartered in the United States, FLUIDDA primarily engages in developing imaging biomarkers utilizing biomedical imaging and advanced engineering methods. These biomarkers have demonstrated their effectiveness in detecting physiological or clinical changes in patients post-intervention, providing valuable insights into intervention efficacy and facilitating enhanced therapy optimization and patient selection. The company also offers a CRO service tailored to imaging, covering the entire spectrum from protocol development to comprehensive data analysis. To ensure the delivery of high-quality services, FLUIDDA has assembled a team of experts, including medical professionals, biomedical scientists, and engineers. Overall, FLUIDDA's unique approach and comprehensive service package position it as a promising player in the pharmaceutical industry.
There is no investment information
No recent news or press coverage available for FLUIDDA.